A Study of Outcomes with Rituximab Induction versus Maintenance Treatments for IgG4-Related Diseases
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 16-000123
Sponsor Protocol Number: 16-000123
About this study
The purpose of this study is to compare IgG4-related disease remission and relapse rates between patients who had induction rituximab treatment with or without follow-up maintenance rituximab therapy, at Mayo Clinic, Rochester between 1 January 2000 and 22 December 2015.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- Age ≥ 18 years at time of study contact
- Received rituximab therapy for IgG4-related disease at Mayo Clinic Rochester between 1 Jan 2000 and 22 Dec 2015
- Subject has agreed to review of medical records for research purposes
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Mark Topazian, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available